Accueil » La R&D d'Unicancer » Les publications de la R&D d'Unicancer » Les publications

Publications de la R&D d'Unicancer

2013

SHARE : a French multicenter phase III trial comparing accelerated partial irradiation versus standard or hypofractionated whole breast irradiation in breast cancer patients at low risk of local recurrence

Clin Adv Hematol Oncol. Feb. 2013

2011

Pharmacokinetic evaluation of the vinorelbine-lapatinib combination in the treatment of breast cancer patients.

Cancer chemotherapy and pharmacology, Décembre 2011;68(6):1529-36

2011

Exemestane for breast-cancer prevention in postmenopausal women.

New England Journal of Medicine, 23 juin 2011 364(25):2381-91

2011

High rate of extra-haematological toxicity compromises dose-dense sequential adjuvant chemotherapy for breast cancer.

British Journal of Cancer, 8 novembre 2011 105(10):1480-6. doi: 10.1038/bjc.2011.414

2012

Transparency in the presentation of trial results may not increase patients' trust in medical researchers.

Clinical Trials, 2012;9(1):90-3.

2012

A refined molecular taxonomy of breast cancer.

Oncogene, 2012;31(9):1196-206

2011

Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer

Breast Cancer Research and Treatment, 2011;127(2):363-73.

2011

Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC-PACS 01 randomized trial.

Breast Cancer Research 2011, 13:R109

2010

Economic issues involved in integrating genomic testing into clinical care: the case of genomic testing to guide decision-making about chemotherapy for breast cancer patients

Breast Cancer Research and Treatment, 9 novembre 2010

2010

DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability

Proceedings of the National Academy of Sciences, USA, 27 juillet 2010